Insider Trading Alert - Freescale Semiconductor And 4 Others Traded By Insiders

Wednesday, July 5, 2013, 60 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $43.14 to $23,490,709.49.

Highlighted Stocks Traded by Insiders:

Freescale Semiconductor (FSL) - FREE Research Report

Lowe Gregg A who is President and CEO at FREESCALE SEMI sold 133,563 shares at $13.69 per share for a total value of $1,828,891.52 on July 2, 2013. Following this transaction, the President and CEO owned 304,451 shares meaning that the stake was reduced by 30.49% with the 133,563 share sell-off.

The shares most recently traded at $14.03, up $0.48, or 3.54% since the insider transaction. Historical insider transactions for Freescale Semiconductor go as follows:

  • 4-Week # shares sold: 920
  • 12-Week # shares sold: 2,619
  • 24-Week # shares sold: 2,619

The average volume for Freescale Semiconductor has been 1.6 million shares per day over the past 30 days. Freescale Semiconductor has a market cap of $3.5 billion and is part of the technology sector and electronics industry. Shares are up 24.61% year to date as of the close of trading on Wednesday.

Freescale Semiconductor, Ltd. provides embedded processing solutions for automotive, networking, industrial, and consumer markets worldwide. Currently there are 5 analysts that rate Freescale Semiconductor a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FSL - FREE

TheStreet Quant Ratings rates Freescale Semiconductor as a sell. The area that we feel has been the company's primary weakness has been its meager revenue growth. Get the full Freescale Semiconductor Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

KLA-Tencor Corporation (KLAC) - FREE Research Report

Kirloskar Virendra A who is SVP & Chief Accounting Officer at KLA-TENCOR CORP sold 334 shares at $54.45 per share for a total value of $18,186.30 on July 3, 2013. Following this transaction, the SVP & Chief Accounting Officer owned 297 shares meaning that the stake was reduced by 52.93% with the 334 share sell-off.

The shares most recently traded at $56.47, up $1.40, or 2.54% since the insider transaction. Historical insider transactions for KLA-Tencor Corporation go as follows:

  • 4-Week # shares sold: 35
  • 12-Week # shares sold: 4,686
  • 24-Week # shares sold: 42,885

The average volume for KLA-Tencor Corporation has been 2.0 million shares per day over the past 30 days. KLA-Tencor Corporation has a market cap of $9.1 billion and is part of the technology sector and electronics industry. Shares are up 15.31% year to date as of the close of trading on Wednesday.

KLA-Tencor Corporation designs, manufactures, and markets process control and yield management solutions for the semiconductor and related nanoelectronics industries. The stock currently has a dividend yield of 2.92%. The company has a P/E ratio of 14.2. Currently there are 8 analysts that rate KLA-Tencor Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KLAC - FREE

TheStreet Quant Ratings rates KLA-Tencor Corporation as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, expanding profit margins, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full KLA-Tencor Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Concur Technologies (CNQR) - FREE Research Report

Pelzer Francis J. who is Chief Financial Officer at CONCUR TECH INC sold 1,000 shares at $83.33 per share for a total value of $83,330.10 on July 5, 2013. Following this transaction, the Chief Financial Officer owned 15,822 shares meaning that the stake was reduced by 5.94% with the 1,000 share sell-off.

The shares most recently traded at $83.78, up $1.16, or 1.4% since the insider transaction. Historical insider transactions for Concur Technologies go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 59,359
  • 24-Week # shares sold: 114,014

The average volume for Concur Technologies has been 578,500 shares per day over the past 30 days. Concur Technologies has a market cap of $4.6 billion and is part of the technology sector and computer software & services industry. Shares are up 20.96% year to date as of the close of trading on Wednesday.

Concur Technologies, Inc. provides integrated travel and expense management solutions for companies of various industries, sizes, and geographies worldwide. Currently there are 6 analysts that rate Concur Technologies a buy, 3 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNQR - FREE

TheStreet Quant Ratings rates Concur Technologies as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Concur Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

ConAgra Foods (CAG) - FREE Research Report

Gregor Joie A who is Director at CONAGRA FOODS bought 28,000 shares at $28.38 per share for a total value of $780,758.90 on July 2, 2013. Following this transaction, the Director owned 71,764 shares meaning that the stake was boosted by 40.14% with the 28,000 share acquisition.

The shares most recently traded at $35.62, down $0.06, or 0.17% since the insider transaction.

The average volume for ConAgra Foods has been 3.4 million shares per day over the past 30 days. ConAgra Foods has a market cap of $14.7 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 19.86% year to date as of the close of trading on Wednesday.

ConAgra Foods, Inc. operates as a food company primarily in North America. The company operates through two segments, Consumer Foods and Commercial Foods. The stock currently has a dividend yield of 2.83%. The company has a P/E ratio of 16.4. Currently there are 7 analysts that rate ConAgra Foods a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAG - FREE

TheStreet Quant Ratings rates ConAgra Foods as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full ConAgra Foods Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Isis Pharmaceuticals (ISIS) - FREE Research Report

O'Neil Patrick R. who is SVP, Legal & General Counsel at ISIS PHARMACEUT bought 1,253 shares at $19.23 per share for a total value of $17,078.52 on July 1, 2013. Following this transaction, the SVP, Legal & General Counsel owned 4,323 shares meaning that the stake was boosted by 34.58% with the 1,253 share acquisition.

The shares most recently traded at $30.00, up $1.50, or 5.26% since the insider transaction. Historical insider transactions for Isis Pharmaceuticals go as follows:

  • 4-Week # shares sold: 215
  • 12-Week # shares sold: 215
  • 24-Week # shares sold: 215

The average volume for Isis Pharmaceuticals has been 1.7 million shares per day over the past 30 days. Isis Pharmaceuticals has a market cap of $3.2 billion and is part of the health care sector and drugs industry. Shares are up 172.7% year to date as of the close of trading on Wednesday.

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. Currently there are 5 analysts that rate Isis Pharmaceuticals a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ISIS - FREE

TheStreet Quant Ratings rates Isis Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. Get the full Isis Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk